Brain Tumor Diagnostics Market Report Highlights
Brain Tumor Diagnostics Market Outlook to 2030
Brain Tumor Diagnostics Market Analysis, 2023
Brain tumor diagnosis refers to diagnostic activities to identify the growth of unnecessary cells in the brain or central spine canal. The $463 million global brain tumor diagnostics market is growing at a rapid rate and is expected to post a CAGR of 5.71% during the period 2023-2030. During 2023, the major revenue contributor to this market was North America, followed by Europe. On the other hand, Asia Pacific presents significant growth opportunities and is poised to register the fastest growth rate of 6.9% over the forecast period.
The global brain tumor diagnostics market is driven by multiple factors including huge unmet market demand, the emergence of new technologies, and funding from diverse organizations coupled with increased life expectancy. Cancer prevalence and geriatric population growth will drive the market size across regions during the decade.
The report classifies the global and regional brain tumor diagnostics market into different types including MRI, CT scan, Tissue Sampling, PET-CT Scan, Cerebral Arteriogram, Lumbar Puncture, Molecular Testing, and EEG. Of these, CT scan accounted for the largest market share worldwide with 38% market share.
Typical diagnosis procedures for patients include- After initial basic neurological examination, imaging techniques such as Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI), which use computer graphics to create brain image is performed. Researchers are currently focusing on developing new scanning techniques to present quicker and clear images. Further, recent advancements in research are driving demand for laboratory tests such as biomarker research Lumbar Puncture (Spinal Tap), and Biopsy tests. Follow-up care for a brain tumor extends over a lifetime and accordingly, the market for the tests remains significant as the same tests are conducted to check the growth or reduction of the tumor.
Brain Tumor Diagnostics Market Share Analysis by Application
Among applications, Meningioma, Glioblastoma, Astrocytoma, Pituitary Tumors, and Others are the categories analyzed in the report. Of these, Meningioma dominated the global market with a 36.6% market share.
Of the two basic types of brain tumors, primary tumors begin and stay in the brain while metastatic tumors start elsewhere in the body and progress to the brain. The primary tumors are categorized as malignant (rapidly growing, invasive, and life-threatening cancer cell growth- often diagnosed under microscopes), and non-malignant (not cancerous cell growth at abnormal speeds, spreading to distant body parts, and when viewed under a microscope, they present distinct borders and rarely spread view).
Metastatic brain tumors refer to cancer cells that originate from other parts of the body and then spread to the brain based on abnormalities of the cells they contain, these tumors are classified as Grade I, II, III, or IV. Grade I tumors are the least malignant while Grade II tumors are relatively slow-growing. On the other hand, Grade III tumors are malignant and Grade IV tumors are the most malignant.
Emerging markets present strong unmet market demand and to enter these untapped markets, vendors are offering advanced diagnostic devices and solutions. Companies focus more on new product launches and intensive marketing activities as the main growth strategies in the market. Leading companies in the industry include- GE Healthcare, Koninklijke Philips N.V., Siemens Healthcare GmbH, Fujifilm Corporation, and Hitachi, Ltd.
Brain Tumor Diagnostics Market Drivers- The increase in the prevalence of neurological disorders drives the market demand
The incidence of neurological disorders is increasing worldwide with nervous system cancers accounting for about 3% of all cancers. The WHO estimates around 450 million people experience neurological disorders across the globe.
The incidence of Brain tumors is higher in the Western than in the East and it is also higher in developed countries than in developing countries. The lowest incidence is in Africa while its highest level is in Europe due to low awareness and availability of diagnostic facilities.
Alzheimer’s disease, epilepsy, Parkinson’s disease, strokes, peripheral neuropathy, paralysis, brain aneurysm, and other cerebral disorders are among the main causes of death and disability-adjusted life years (DALYs).
Brain disorders cost around $1 trillion in Europe and around $1.5 trillion in the US. Advancements in technology for neurological diagnosis and surgeries are the main factors driving the market for diagnostics. The awareness about screening and treating various neurological disorders, marketing campaigns organized by medical companies and research institutions, and adoption of new devices with advanced features will drive market growth.
Brain Tumor Diagnostics Market Trends- Availability of funds and grants for R&D encourages innovation
Governments across markets provide funding opportunities for R&D through multiple agencies, departments, and institutions. Companies also form collaborations with universities for new product development.
The European Commission supports small and medium companies and institutes through financial assistance. Programs such as Horizon 2020 encourage collaboration between scientific, medical, technological, and industrial communities. Cancer research in Europe also receives significant funding from the public and governments.
National Brain Tumor Society, National Cancer Institute, National Institutes of Health, Neurological Disorders and Stroke, National Brain Tumor Society, and other associations are working on funding research in Brain tumors and other cancers. For instance, in 2018, National Cancer Institute (NCI) funded $220.9 million for Brain and CNS research.
The availability of funding from these institutes, companies, and government bodies will provide an impetus to the diagnostics market research.
Brain Tumor Diagnostics Companies included in the Report-
Brain Tumor Diagnostics Market Report Segmentation
1. Executive Summary
1.1 Introduction to Brain Tumor Diagnostics Markets
1.2 Brain Tumor Diagnostics Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Brain Tumor Diagnostics Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Brain Tumor Diagnostics Market Trends
3.1.1 Increasing Healthcare Expenditure worldwide
3.1.2 Increase in prevalence of neurological disorders
3.1.3 Availability of funds and grants for R&D encourages innovation
3.2 Key Brain Tumor Diagnostics Market Growth Drivers
3.2.1 Focus on emerging countries
3.2.2 Companies focus on biomarkers for Glioblastoma Diagnosis
3.2.3 Computer-Assisted Diagnostic Procedure Enables Earlier Detection of Brain Tumor Growth
3.2.4 Private diagnostic and imaging centers hold the key for future
3.3 Key Brain Tumor Diagnostics Market Growth Restraints
3.3.1 High costs of Diagnosis restrict wide expansion
3.3.2 Limited skilled professionals observed in developing countries
4 Brain Tumor Diagnostics Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts: Brain Tumor Diagnostics Market Size Outlook to 2030
4.2 Reference Growth Case Scenario Forecasts: Brain Tumor Diagnostics Market Size Outlook to 2030
4.3 High Growth Case Scenario Forecasts: Brain Tumor Diagnostics Market Size Outlook to 2030
5. Brain Tumor Diagnostics Market Segmentation- Outlook by Type
5.1 Brain Tumor Diagnostics Market Share Analysis by Type, 2023
5.2 CT Scan Market Outlook to 2030
5.3 MRI Scan Market Outlook to 2030
5.4 PET -CT Scan Market Outlook to 2030
5.5 Tissue Sampling Market Outlook to 2030
5.6 Celebral Arteriogram Market Outlook to 2030
5.7 Lumbar Puncture Market Outlook to 2030
5.8 Molecular Testing Market Outlook to 2030
5.9 EEG Market Outlook to 2030
7. Brain Tumor Diagnostics Market Segmentation- Outlook by Indication
7.1 Brain Tumor Diagnostics Market Share Analysis by Indication, 2023
7.2 Meningioma: Brain Tumor Diagnostics Market Revenue Outlook to 2030
7.3 Glioblastoma: Brain Tumor Diagnostics Market Revenue Outlook to 2030
7.4 Astrocytoma: Brain Tumor Diagnostics Market Revenue Outlook to 2030
7.5 Pituitary Tumors: Brain Tumor Diagnostics Market Revenue Outlook to 2030
7.6 Other Conditions: Brain Tumor Diagnostics Market Revenue Outlook to 2030
8. North America Brain Tumor Diagnostics Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Brain Tumor Diagnostics Market Growth Opportunities
8.2.1 North America Brain Tumor Diagnostics Market Outlook by Type, 2021 to 2030
8.2.3 North America Brain Tumor Diagnostics Market Outlook by End-User Industry, 2021 to 2030
8.2.4 North America Brain Tumor Diagnostics Market Outlook by Country, 2021 to 2030
8.3 United States Brain Tumor Diagnostics Market Outlook, 2021 to 2030
8.4 Canada Brain Tumor Diagnostics Market Outlook, 2021 to 2030
8.5 Mexico Brain Tumor Diagnostics Market Outlook, 2021 to 2030
9. Europe Brain Tumor Diagnostics Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Brain Tumor Diagnostics Market Growth Opportunities
9.2.1 Europe Brain Tumor Diagnostics Market Outlook by Type, 2021 to 2030
9.2.3 Europe Brain Tumor Diagnostics Market Outlook by End-User Industry, 2021 to 2030
9.2.4 Europe Brain Tumor Diagnostics Market Outlook by Country, 2021 to 2030
9.3 Germany Brain Tumor Diagnostics Market Outlook, 2021 to 2030
9.4 France Brain Tumor Diagnostics Market Outlook, 2021 to 2030
9.5 United Kingdom Brain Tumor Diagnostics Market Outlook, 2021 to 2030
9.6 Spain Brain Tumor Diagnostics Market Outlook, 2021 to 2030
9.7 Italy Brain Tumor Diagnostics Market Outlook, 2021 to 2030
9.8 Other Europe Brain Tumor Diagnostics Market Outlook, 2021 to 2030
10. Asia Pacific Brain Tumor Diagnostics Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Brain Tumor Diagnostics Market Growth Opportunities
10.2.1 Asia Pacific Brain Tumor Diagnostics Market Outlook by Type, 2021 to 2030
10.2.3 Asia Pacific Brain Tumor Diagnostics Market Outlook by End-User Industry, 2021 to 2030
10.2.4 Asia Pacific Brain Tumor Diagnostics Market Outlook by Country, 2021 to 2030
10.3 China Brain Tumor Diagnostics Market Outlook, 2021 to 2030
10.4 Japan Brain Tumor Diagnostics Market Outlook, 2021 to 2030
10.5 India Brain Tumor Diagnostics Market Outlook, 2021 to 2030
10.6 South Korea Brain Tumor Diagnostics Market Outlook, 2021 to 2030
10.7 Indonesia Brain Tumor Diagnostics Market Outlook, 2021 to 2030
10.8 Other Asia Pacific Brain Tumor Diagnostics Market Outlook, 2021 to 2030
11. South and Central America Brain Tumor Diagnostics Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 South and Central America Brain Tumor Diagnostics Market Growth Opportunities
11.2.1 South and Central America Brain Tumor Diagnostics Market Outlook by Type, 2021 to 2030
11.2.3 South and Central America Brain Tumor Diagnostics Market Outlook by End-User Industry, 2021 to 2030
11.2.4 South and Central America Brain Tumor Diagnostics Market Outlook by Country, 2021 to 2030
11.3 Brazil Brain Tumor Diagnostics Market Outlook, 2021 to 2030
11.4 Argentina Brain Tumor Diagnostics Market Outlook, 2021 to 2030
11.5 Other Latin America Brain Tumor Diagnostics Market Outlook, 2021 to 2030
12. Middle East and Africa Brain Tumor Diagnostics Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and Africa Brain Tumor Diagnostics Market Growth Opportunities
12.2.1 Middle East and Africa Brain Tumor Diagnostics Market Outlook by Type, 2021 to 2030
12.2.3 Middle East and Africa Brain Tumor Diagnostics Market Outlook by End-User Industry, 2021 to 2030
12.2.4 Middle East and Africa Brain Tumor Diagnostics Market Outlook by Country, 2021 to 2030
12.3 Saudi Arabia Brain Tumor Diagnostics Market Outlook, 2021 to 2030
12.4 United Arab Emirates (the UAE) Brain Tumor Diagnostics Market Outlook, 2021 to 2030
12.5 Other Middle East Brain Tumor Diagnostics Market Outlook, 2021 to 2030
12.6 Egypt Brain Tumor Diagnostics Market Outlook, 2021 to 2030
12.7 South Africa Brain Tumor Diagnostics Market Outlook, 2021 to 2030
12.8 Other Africa Brain Tumor Diagnostics Market Outlook, 2021 to 2030
13. Profiles of major world Brain Tumor Diagnostics Companies
13.1 Koninklijke Philips N.V
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.2 Hitachi Ltd
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.3 Thermo fisher Scientific, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.4 Siemens Healthineers AG
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.5 NantOmics
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.6 Fujifilm Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.7 GE Healthcare
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.8 Biocept Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.9 Canon Medical Systems
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
Increasing Healthcare Expenditure worldwide, prevalence of neurological disorders, Availability of funds and grants for R&D, Focus on emerging countries , focus on biomarkers for Glioblastoma, Computer-Assisted Diagnostic Procedure Enables Earlier Detection of Brain Tumor Growth, Private diagnostic and imaging centres hold the key for future
The global brain tumor diagnostics market stood at $488.5 million in 2023
The brain tumor diagnostics market is poised to increase at a growth rate of 5.71% between 2023 and 2030, compounded annually
Key brain tumor diagnostics companies analyzed in the report are Koninklijke Philips N.V, Hitachi Ltd., Thermo fisher Scientific, Siemens Healthineers AG, NantOmics, Fujifilm Corporation, GE Healthcare, Biocept Inc, and Canon Medical Systems
CT Scan held the dominant share of over 38% market revenue in Brain tumor diagnostics industry. Other diagnostic types include MRI, PET -CT Scan, Tissue Sampling, Celebral Arteriogram, Lumbar Puncture, Molecular Testing, and EEG